Vaccines

12 Feb 2008 Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
07 Feb 2008 Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II
07 Feb 2008 GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference
22 Jan 2008 Medicago’s Pandemic Flu Vaccine Provides 100% Protection in Mice at Low Doses
17 Jan 2008 ICLL receives manufacturer's licence for future commercial manufacturing of its JE vaccine
16 Jan 2008 Intercell and PATH Malaria Vaccine Initiative Announce New Collaboration for Vaccine against Malaria
15 Jan 2008 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
14 Jan 2008 Nventa completes evaluation of second cohort in HSPE7 Phase 1 cervical dysplasia trial
09 Jan 2008 New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants
07 Jan 2008 Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
03 Jan 2008 Acambis reports positive data from trials of universal influenza A vaccine
31 Dec 2007 IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
27 Dec 2007 Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
24 Dec 2007 Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
21 Dec 2007 Curalogic announces top line results from Phase III clinical study with the
21 Dec 2007 Aeras and Crucell Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras commits a further USD 5 million to the development of the tuberculosis vaccine
20 Dec 2007 Successful Collaboration between US Army and Intercell Towards a Novel Vaccine Against JE
20 Dec 2007 Novavax Announces Favorable Interim Results From Human Clinical Trial
20 Dec 2007 Genitope Corporation Reports Initial Results of Phase 3 Clinical Trial of MyVax(R) Personalized Immunotherapy
19 Dec 2007 GlobeImmune Announces Initiation of Phase II Clinical Trial of GI-5005 in Patients with Chronic Hepatitis C
17 Dec 2007 Lilly and BioMS Medical Announce Global Licensing and Development Agreement
17 Dec 2007 GlaxoSmithKline receives FDA 'complete response' letter for cervical cancer vaccine
16 Dec 2007 Intercell receives Milestone Payment from Merck & Co. Inc.
14 Dec 2007 IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
12 Dec 2007 Geron receives milestone payment from merck triggered by ind filing for telomerase cancer vaccine candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top